ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN (Rylaze) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the Generic Name

ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN

What is the Trade Name for ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN

Rylaze

What is the Indication for ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN

  • 1 INDICATIONS AND USAGE RYLAZE is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adult and pediatric patients 1 month or older who have developed hypersensitivity to E. coli -derived asparaginase. RYLAZE is an asparagine specific enzyme indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adult and pediatric patients 1 month or older who have developed hypersensitivity to E. coli -derived asparaginase. ( 1 )

 

 

View Our Nursing Pharmacology Course

 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.
[NextGen]
[NextGen]